Medicinova Inc.

MNOV Nasdaq SEC CIK 1226616
Follow Medicinova Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $138.6K +12.4% vs same quarter last year
Net income −$2.8M +6.8% vs same quarter last year
EPS, diluted −$0.06 +0% vs same quarter last year
Operating cash flow −$2.4M −40.1% vs same quarter last year
Revenue by quarter
$134.6K
$123.3K
$151.7K
$187K
$458.4K
$138.6K
Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$20M−$10M$0$10MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$409.7K-
FY24--
FY23$1M-
FY22-−$14.1M
FY21$4M−$10.1M
FY20-−$13.9M
FY19-−$12.9M
FY18-−$14.7M
FY17-−$11.2M
FY16-−$10.9M
FY15-−$8.8M
FY14-−$9.2M
FY13-−$4M
FY12$802.6K−$11M
FY11-−$17.7M
MarginsShare of revenue
−4000%−3000%−2000%−1000%0%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearOperating margin
FY25−3242.5%
FY24-
FY23−990%
FY22-
FY21−253%
FY20-
FY19-
FY18-
FY17-
FY16-
FY15-
FY14-
FY13-
FY12−1363.8%
FY11-
Free cash flowOperating cash flow minus capital expenditure
−$15M−$10M−$5M$0$5MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$9.8M
FY24−$10.6M
FY23−$7.5M
FY22−$12.9M
FY21−$9.4M
FY20−$10.9M
FY19−$9.1M
FY18−$9.1M
FY17-
FY16−$6.6M
FY15−$7.2M
FY14$813K
FY13−$10.7M
FY12−$11.9M
FY11−$13.3M